• Cortela Tablets: anti-inflammatory medication for relief of arthritis pain.
• Can reduce symptoms of inflammation & stiffness.
• May improve joint mobility, function & quality of life.
Description
Cortela Tablets – Composition & Storage
These Cortela tablets contain 10mg of Daclatasvir and 60mg of Sofosbuvir as their active ingredients. The inactive ingredients of Cortela tablets may vary depending on the specific tablet formulation.
The tablets should be stored in a cool, dry place away from direct sunlight and moisture. It is recommended that the tablets be kept out of reach of children and pets.
Product Information & Uses
Cortela are designed to treat people with chronic hepatitis C virus (HCV) genotypes 1, 2, 3 or 4 infection who are 18 years or older.
They work to block the virus’s ability to reproduce itself in the body and can reduce levels of virus in patients with HCV infections over time.
Cortela tablets may also help improve patients’ overall clinical outcomes, such as sustained virologic response (SVR).
Benefits & Side Effects
Cortela tablets offer several benefits for HCV patients, including more effective clearance for complex cases involving multiple genotypes,
Fewer side effects than other treatments, fewer trips to the doctor’s office due to convenient home dosing schedules and faster SVR rates for some genotypes when compared with other therapies.
Common side effects may include headache, fatigue and nausea but these are rarely serious enough to require medical attention.
How it Works
Cortela works by targeting proteins produced by the HCV virus that would normally allow it to infect cells in your body and reproduce quickly throughout your bloodstream. By targeting these viral proteins directly,
Cortela reduces levels of virus in patients over time until those infected achieve a sustained virologic response (SVR) where they become infection-free without any further treatment necessary.
FAQs
Q1: What Is Cortela?
A1: Cortela is an oral tablet designed to treat chronic hep C virus (HCV) infections using two active ingredients: Daclatasvir (10 mg) and Sofosbuvir (60 mg).
This combined therapy is effective against all major HCV genotypes and helps many achieve a sustained virologic response rate quickly when compared with other types of treatment available.*
Q2: How Will I Know My Treatment Is Working?
A2: Your doctor will likely run blood tests during your course of treatment to ensure your viral load is reducing steadily until you become infection-free without any further treatment necessary—this process is known as a sustained virologic response (SVR).
If you ever have any questions or concerns about how well your treatment is working during this process, please reach out to your health care provider right away for guidance.*
